CSL Executive and Leadership Team

Gordon Naylor, the Interim Chief Executive Officer & Managing Director at CSL, directs the overarching strategic vision for the global biotechnology enterprise. Overseeing the integration of research and commercial operations, the Interim Chief Executive Officer & Managing Director ensures alignment with the core mission of delivering lifesaving therapies. This leadership role involves managing complex stakeholder relationships and guiding the organization through significant market shifts in the pharmaceutical sector. By prioritizing operational excellence and long-term sustainability, Gordon Naylor drives the company toward achieving ambitious growth targets in the hemophilia and immunology markets. The Interim Chief Executive Officer & Managing Director maintains a focus on scaling production capabilities to meet rising international demand for vaccines and specialized medicines. Through rigorous oversight of corporate governance, Naylor secures the stability of the organization while fostering a culture of scientific innovation and patient-centric care across all global business units.

Ken Lim, the Chief Financial Officer at CSL, manages the global financial architecture and capital allocation strategies for the biotechnology firm. Overseeing fiscal planning, the Chief Financial Officer ensures the company maintains the necessary liquidity to fund intensive research and development pipelines for lifesaving medicines. This role involves coordinating with the Board to optimize investment in nephrology and immunology assets. By implementing robust financial controls, Ken Lim drives efficiency across international operations, supporting the expansion of the vaccine portfolio. The Chief Financial Officer monitors market volatility and currency fluctuations to protect the bottom line while facilitating sustainable growth. Through strategic financial modeling, Lim provides the necessary data to support high-stakes decisions regarding manufacturing infrastructure and global supply chain investments. Ultimately, the Chief Financial Officer secures the financial health required to sustain the long-term mission of saving lives through advanced medical technology.

Emiliano Chiaramonte, the Chief Financial Officer, LATAM (South) at CSL, directs the financial operations and strategic planning for the company's southern Latin American markets. Overseeing regional budget management, the Chief Financial Officer, LATAM (South) ensures that resources are allocated effectively to support the distribution of lifesaving medicines. This role involves navigating complex economic environments to maintain profitability and operational stability. By optimizing local financial processes, Emiliano Chiaramonte drives the growth of the regional business unit. The Chief Financial Officer, LATAM (South) collaborates with global leadership to align regional performance with the broader corporate strategy. Through rigorous financial analysis, Chiaramonte identifies opportunities for cost reduction and revenue enhancement in the nephrology and vaccine sectors. This leadership position remains essential for sustaining the company's presence in the region and ensuring that patients have consistent access to critical therapies through efficient financial management and local market expertise.

Jody Long, the Administrative Advisor To Chief Financial Officer at CSL, directs the operational support and strategic coordination for the finance department. Overseeing the administrative workflows that enable the Chief Financial Officer to execute high-level financial strategies, the Administrative Advisor To Chief Financial Officer ensures that the office functions with maximum efficiency. This role involves managing complex schedules, preparing executive briefings, and facilitating communication between the finance team and other corporate divisions. By streamlining internal processes, Jody Long drives the productivity of the financial leadership team. The Administrative Advisor To Chief Financial Officer monitors key performance indicators to assist in the preparation of financial reports and board presentations. Through meticulous organization and project management, Long supports the successful implementation of global fiscal initiatives. This leadership function provides the necessary administrative foundation for the company to manage its extensive portfolio of lifesaving medicines and maintain financial discipline.

Hamza Shanaa, the Manager Chief Marketing Officer Quality at CSL, directs the intersection of brand strategy and quality assurance for the company's therapeutic portfolio. Overseeing the alignment of marketing initiatives with rigorous regulatory standards, the Manager Chief Marketing Officer Quality ensures that all promotional activities accurately reflect the efficacy of lifesaving treatments. This role involves auditing communication channels to maintain compliance while driving market penetration for immune deficiency therapies. By integrating quality metrics into the marketing lifecycle, Hamza Shanaa optimizes the delivery of medical information to healthcare providers. The Manager Chief Marketing Officer Quality collaborates with cross-functional teams to refine the positioning of complex biological products in competitive markets. Through meticulous oversight of brand integrity, Shanaa supports the broader organizational goal of maintaining trust with patients and medical professionals. This leadership function ensures that every marketing campaign adheres to the highest safety and quality benchmarks established by the firm.

Phyllis Post, the Vice President and Chief Information Officer, CSL Behring, Seqirus and Vifor I & T at CSL, architects the digital infrastructure supporting the company's diverse biotechnology divisions. Overseeing the integration of information technology across the Behring, Seqirus, and Vifor business units, the Vice President and Chief Information Officer, CSL Behring, Seqirus and Vifor I & T ensures seamless data flow for research and manufacturing operations. This role involves deploying advanced analytics to accelerate the development of vaccines and therapies. By modernizing enterprise systems, Phyllis Post drives operational agility and enhances the security of sensitive patient data. The Vice President and Chief Information Officer, CSL Behring, Seqirus and Vifor I & T manages large-scale digital transformation projects that support global market reach. Through strategic technology investments, Post enables the organization to scale production and improve supply chain visibility. This leadership position remains critical for maintaining the technological edge required to deliver lifesaving medicines to patients worldwide.

Eric McKay, the Regional Category Manager & Chief Marketing Officer, Research & Development at CSL, directs the commercialization strategy for emerging therapies within the research pipeline. Overseeing the transition of products from clinical development to market launch, the Regional Category Manager & Chief Marketing Officer, Research & Development ensures that new innovations meet specific patient needs in nephrology and immunology. This role involves analyzing regional market trends to tailor the introduction of complex medicines. By bridging the gap between scientific discovery and commercial viability, Eric McKay drives the adoption of next-generation treatments. The Regional Category Manager & Chief Marketing Officer, Research & Development collaborates with R&D teams to define the value proposition of new assets. Through targeted market analysis, McKay supports the expansion of the company's therapeutic footprint. This leadership function ensures that the research pipeline remains aligned with the overarching mission of providing advanced medical solutions to global patient populations.

Candice Nieves, the Manager Chief Marketing Officer Quality at CSL, directs the quality management systems governing the marketing of the company's specialized medicine portfolio. Overseeing the compliance of promotional materials, the Manager Chief Marketing Officer Quality ensures that all messaging aligns with the rigorous safety standards required for hemophilia and immune deficiency therapies. This role involves monitoring the quality of customer engagement strategies to ensure accuracy and transparency. By implementing standardized quality protocols, Candice Nieves drives consistency across all marketing communications. The Manager Chief Marketing Officer Quality works closely with regulatory affairs to mitigate risks associated with product promotion. Through the application of strict quality controls, Nieves supports the company's reputation for excellence in the biotechnology industry. This leadership role focuses on maintaining the integrity of the brand while expanding the reach of lifesaving treatments to diverse patient groups across international markets.

Amanda Taylor, the Chief Marketing Officer, Campaign & Manager (Americas) at CSL, directs the marketing campaigns and regional management strategies across the Americas. Overseeing the promotion of the company's therapeutic portfolio, the Chief Marketing Officer, Campaign & Manager (Americas) ensures that healthcare providers and patients receive clear information regarding the benefits of the firm's lifesaving medicines. This role involves developing localized marketing strategies that address the specific needs of the North and South American markets. By executing high-impact campaigns, Amanda Taylor drives the adoption of therapies for immune deficiencies and hemophilia. The Chief Marketing Officer, Campaign & Manager (Americas) collaborates with regional sales teams to maximize market share and improve patient outcomes. Through strategic brand management, Taylor strengthens the company's position as a leader in the biotechnology sector. This leadership function focuses on expanding the reach of critical treatments while maintaining the highest standards of medical communication.

Ruby Eappen, the Global Quality Manager, Supplier & Chief Marketing Officer at CSL, directs the quality assurance processes for the global supply chain while overseeing marketing alignment. Overseeing the vetting of suppliers, the Global Quality Manager, Supplier & Chief Marketing Officer ensures that all raw materials meet the stringent safety requirements necessary for the production of lifesaving medicines. This role involves integrating quality standards into the marketing strategy to ensure that the company's brand promise remains consistent with product performance. By managing supplier relationships, Ruby Eappen drives the reliability of the manufacturing process. The Global Quality Manager, Supplier & Chief Marketing Officer collaborates with procurement and marketing teams to maintain the integrity of the entire product lifecycle. Through rigorous oversight, Eappen supports the company's commitment to delivering high-quality therapies to patients worldwide. This leadership position ensures that quality remains the cornerstone of both the supply chain and the market presence.